1-3 of 3
Kazuo Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2

Norihito Kawasaki, Yoko Ichikawa, Ichiro Matsuo, Kiichiro Totani, Naoki Matsumoto, Yukishige Ito, Kazuo Yamamoto
Journal: Blood
Blood (2008) 111 (4): 1972–1979.
https://doi.org/10.1182/blood-2007-06-097022
Published: 2008
Journal Articles

Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency

Brief Report
Beat Nyfeler, Yukiko Kamiya, Françoise Boehlen, Kazuo Yamamoto, Koichi Kato, Philippe de Moerloose, Hans-Peter Hauri, Marguerite Neerman-Arbez
Journal: Blood
Blood (2008) 111 (3): 1299–1301.
https://doi.org/10.1182/blood-2007-09-112854
Published: 2008
Journal Articles

Transactivation of CCL20 Gene by CD30 in Hodgkin’s Lymphoma.

Naoki Mori, MD, PhD, Taeko Okudaira, M.D., Ph.D., Kazuo Yamamoto, M.D., Ph.D., Ryouichi Horie, M.D., Ph.D., Toshiki Watanabe, M.D., Ph.D., Toshifumi Matsuyama, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2258.
https://doi.org/10.1182/blood.V108.11.2258.2258
Published: 2006